ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RVMD Revolution Medicines Inc

38.62
-1.12 (-2.82%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 844,927
Bid Price 38.00
Ask Price 40.20
News -
Day High 39.50

Low
15.4401

52 Week Range

High
41.205

Day Low 37.90
Company Name Stock Ticker Symbol Market Type
Revolution Medicines Inc RVMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.12 -2.82% 38.62 20:00:00
Open Price Low Price High Price Close Price Prev Close
39.34 37.90 39.50 38.62 39.74
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,894 844,927 $ 38.70 $ 32,695,277 - 15.4401 - 41.205
Last Trade Time Type Quantity Stock Price Currency
16:49:38 formt 3,268 $ 38.62 USD

Revolution Medicines (RVMD) Options Flow Summary

Overall Flow

Bullish

Net Premium

618k

Calls / Puts

300.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Revolution Medicines Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
19.76M 164.69M - 11.58M -436.37M -2.65 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Revolution Medicines News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RVMD Message Board. Create One! See More Posts on RVMD Message Board See More Message Board Posts

Historical RVMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week39.5340.7037.9039.76923,684-0.91-2.30%
1 Month39.3841.20536.60539.291,172,260-0.76-1.93%
3 Months32.4141.20529.5536.851,215,6216.2119.16%
6 Months26.5041.20525.5832.451,389,74712.1245.74%
1 Year25.6041.20515.440128.671,603,90113.0250.86%
3 Years34.4741.20514.0826.211,073,9514.1512.04%
5 Years29.3556.1814.0827.76884,0039.2731.58%

Revolution Medicines Description

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Your Recent History

Delayed Upgrade Clock